Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2006-05-03
2011-11-29
Russel, Jeffrey E (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C560S153000, C560S154000
Reexamination Certificate
active
08067467
ABSTRACT:
The present invention relates to compounds of the formula (I) wherein X1and X2independently represent O, NH or S, R1and R2are independently selected from the group consisting of a C1-C30hydrocarbyl group, an amino acid bonded via an amide bond or a peptide bonded via an amide bond each having up to 200 amino acids, the conjugated residue X1or X2in this case being NH, and hydrogen, both radicals R1and R2preferably not being H, wherein R3is a residue selected from group consisting of —S—R6, wherein R6is a C1-C30hydrocarbyl group, at least one of R1and R2not being H when X1and X2are oxygen, —S—CH2—CH(NH2)(COOH) (cysteine-S-yl), a homologue or derivative (e.g. N-acetyl cysteine-S-yl) thereof, a peptide having up to 200 amino acids which contains at least one amino acid radical with a thiol group, preferably a cysteine radical, and is bonded via the thio sulfur, preferably via the cysteine sulfur (peptide-S-yl), coenzyme A which is bonded via a thiol group or fragments thereof, acyl carrier protein bonded via a thiol group, and dihydrolipoic acid bonded via a thiol group, and pharmaceutically acceptable salts thereof. The present invention also relates to the use of these compounds for preparing a drug and drugs containing the same.
REFERENCES:
patent: 3345327 (1967-10-01), Dexter et al.
patent: 2004/0038889 (2004-02-01), Joshi et al.
patent: 579222 (1994-01-01), None
patent: WO 9402445 (1994-02-01), None
Ailman, “Synthesis of O, O-Dimethyl S-(1,2-Dicarbethoxy) ethyl Phosphorothioate (Maloxon) and Related Compounds from Trialkyl Phosphites and Organic Disulfides,”Journal of Organic Chemistry, 30(4): 1074-1077(1965).
Brophy et al., “β-Carbonyl Substituted Glutathione Conjugates as Inhinitors of O. Volvulus GST2,”Bioorganic&Medicinal Chemistry Letters, 10(9): 979-981 (2000).
Cui et al., “Metabolism of the Nephrotoxicant N-(3,5-Dichlorophenyl) succinmide in Rats: Evidence for Bioactivation Through Alcohol-O-glucuronidation and O-Sulfaction,”Chemical Research in Toxicology, 18(6): 991-1003 (2005).
Endo et al., “Anionic 3,4-Diaza [3,3] Sigmatropic Rearrangements of N,N'-Diacylhydrazines,”Tetrahedron Letters, 32(35): 4517-4520 (1991).
Fushiya et al., “(2R), (1'R) and (2R), (1'S)-2-Amino-3-(1,2-dicarboxyethylthio) propanoic Acids fromAmanita pantherina, Antagonists of N-Methyl-D-aspartic Acid (NMDA) Receptors,”Chemical&Pharmaceutical Bulletin, 41(3): 484-486 (1993).
Henesey et al., “Renal Damage, Metabolism and Covalent Binding Following Administration of the Nephrotoxicant N-(3,5-Dichlorophenyl) Succinimide (NDPS) to Male Fischer 344 Rats,”Toxicology, 170(3): 187-200 (2002).
McKay et al., “By-Product Analogues for Bovine Carboxypeptidase B,”American Chemical Society, 17(3): 401-405 (1978).
Neumann et al., “Peptide Liposomes from Amphiphilic Amino Acids,”American Chemical Society, 108(30): 487-490 (1986).
Pacanis et al., “Studies on Chemical and Enzymatic Synthesis of Maleyl-CoA,”The Journal of Biological Chemistry, 256(24): 13030-13034 (1981).
Sakaue et al., “Physiological Activities of S-(1,2-Dicarboxyethyl) glutathione as an Intrinsic Tripeptide Present in Liver, Heart and Lens,”Arzneimittel-Forschung, Drug Research, 42(12): 1482-1486 (1992).
Written Opinion mailed Jan. 16, 2007, for International Application No. PCT/EP2006/004134, filed May 3, 2006.
International Search Report mailed Jan. 16, 2007, for International Application No. PCT/EP2006/004134, filed May 3, 2006.
International Preliminary Examination Report completed May 9, 2007, for International Application No. PCT/EP2006/004134, filed May 3, 2006.
Joshi Rajendra Kumar
Schmidt Thomas J.
Strebel Hans-Peter
Ulrichová Jitka
Biogen Idec International GmbH
Russel Jeffrey E
Sterne Kessler Goldstein & Fox P.L.L.C.
LandOfFree
Thiosuccinic acid derivatives and the use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiosuccinic acid derivatives and the use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiosuccinic acid derivatives and the use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4273584